YOLFTbeta
Simris Alg AB (publ)

Simris Alg AB (publ)

SIMRIS-B · ST · Healthcare / Biotechnology

0.0874SEK+0.01 (+16.22%)

Price History

Full chart

Market Stats

Previous Close0.0752
Open0.0992
Day Range0.0802 – 0.0992
52-Week Range0.0402 – 0.195
Volume376.62K
Market Cap148.48M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.03
Dividend Yield0.00%
Beta0.88
50-Day Avg0.1061
200-Day Avg0.093

About

Simris Group AB (PUBL), a biotechnology company, develops antibody-drug conjugate (ADC) payloads in Sweden and internationally. The company develops, manufactures, and sells bioactive substances from cultured microalgae and cyanobacteria. It also offers cosmetics and skincare products; biopharmaceuticals; and dietary supplements. The company was incorporated in 2011 and is headquartered in Hammenhög, Sweden.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEODaniel Kubitza
  • Employees5
  • HeadquartersHerrestadsvAegen 24A, Hammenhög, Sweden, 276 50, Sweden
  • Websitehttps://www.simrisgroup.com

Leadership

  • Mr. Christoffer TellChief Financial Officer · b. 1987
  • Daniel KubitzaInterim Chief Executive Officer
  • Prof. Andreas PahlChief Executive Officer of Simris Biologics GmbH

Financials

Income Statement

Currency: SEK2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue645.45K2.02M55.00K283.00K726.23K851.63K761.81K1.74M2.17M6.14M4.08M4.35M2.89M1.61M
Growth (%)-+213.05%-97.28%+414.55%+156.62%+17.27%-10.55%+128.80%+24.27%+183.33%-33.52%+6.72%-33.62%-44.12%
Cost of Revenue40.94K26.46K-1.02M-335.00K1.47M-1.62M1.06M3.13M4.92M8.20M4.82M2.35M1.67M32.96M
Gross Profit604.51K1.99M1.08M618.00K-741.76K2.47M-296.70K-1.39M-2.75M-2.07M-742.00K2.01M1.22M-31.34M
Gross Margin93.66%98.69%1961.82%218.37%-102.14%290.06%-38.95%-79.69%-126.92%-33.68%-18.19%46.10%42.11%-1940.68%
Operating Expense3.46M5.97M9.57M12.20M18.02M25.08M22.37M23.24M20.95M26.86M23.91M38.64M35.93M0
Operating Income-2.85M-3.98M-8.49M-11.58M-18.76M-22.61M-22.67M-24.63M-23.69M-28.93M-24.66M-36.63M-34.71M-31.34M
Operating Margin-441.84%-196.86%-15438.18%-4090.81%-2582.82%-2654.78%-2975.93%-1412.85%-1093.91%-471.37%-604.34%-841.41%-1201.18%-1940.68%
EBITDA-2.82M-3.91M-7.97M-10.83M-17.16M-19.13M-19.19M-21.50M-20.66M-24.81M-18.00M-22.36M-17.59M-17.32M
EBITDA Margin-437.30%-193.42%-14494.55%-3827.92%-2363.11%-2246.04%-2519.25%-1233.39%-954.02%-404.22%-441.30%-513.62%-608.75%-1072.38%
Net Income-2.86M-3.95M-8.45M-11.81M-19.35M-22.98M-23.97M-26.91M-25.60M-28.36M-24.42M-37.30M-34.60M-26.81M
Net Income Margin-443.85%-195.51%-15365.45%-4172.08%-2664.20%-2698.05%-3146.57%-1544.06%-1182.09%-462.05%-598.58%-856.80%-1197.40%-1660.12%
R&D-----432.49K433.00K98.00K-90.00K----
R&D as % of Total Revenue-----50.78%56.84%5.62%-1.47%----
Interest Expense--12.00K241.00K570.33K354.28K1.32M2.38M1.84M616.00K1.11M3.99M3.50M441.00K
Interest Expense % of Total Revenue--21.82%85.16%78.53%41.60%173.00%136.60%85.09%10.04%27.18%91.64%121.25%27.31%

Balance Sheet

Currency: SEK2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets6.71M6.33M10.86M55.62M76.35M54.39M49.84M52.21M57.06M29.20M185.71M174.55M157.06M148.38M
Total Liabilities633.30K702.52K1.08M16.94M11.03M11.71M10.05M17.21M9.64M10.98M162.68M148.94M151.42M148.85M
Total Equity6.08M5.63M9.78M38.68M65.32M42.68M39.78M35.00M47.42M18.22M23.03M25.61M5.64M-470.00K
Cash4.82M2.66M4.86M25.66M32.13M7.43M4.42M7.86M16.51M961.00K3.99M5.67M1.95M1.47M
Total Debt-35.71K7.00K7.33M7.23M6.72M5.69M4.70M3.99M3.13M2.13M2.67M2.04M87.68M
Net Debt-4.82M-2.63M-4.86M-18.34M-24.90M-705.84K1.27M-3.15M-12.52M2.17M-1.86M-3.00M93.00K86.22M

Cash Flow

Currency: SEK2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow---8.73M-8.35M-18.64M-23.62M-22.27M-17.32M-19.48M-18.14M-18.19M-36.35M-18.02M-16.05M
Investing Cash Flow---1.66M-24.00M-15.57M-301.09K-169.88K-356.00K-286.00K-253.00K-22.38M-1.61M-613.00K-224.00K
Financing Cash Flow--12.59M53.16M40.68M-781.42K19.43M21.11M28.42M2.84M43.60M39.63M14.91M15.79M
Capital Expenditure001.66M24.00M15.58M301.09K169.88K356.00K286.00K253.00K22.38M1.61M613.00K16.05M
Free Cash Flow---10.39M-32.36M-34.22M-23.92M-22.44M-17.67M-19.77M-18.39M-40.57M-37.96M-18.63M-16.27M
FCF to OCF--118.96%387.40%183.55%101.27%100.76%102.06%101.47%101.39%223.06%104.43%103.40%101.40%

Earnings

Report DateJun 30, 2016Sep 30, 2016Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Apr 5, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate---------------------------------------
EPS Actual-0.20-0.14-0.22-0.25-0.28-0.24-0.22-0.31-0.22-0.17-0.26-0.24-0.19-0.16-0.19-0.07-0.07-0.06-0.06-0.09-0.03-0.03-0.03-0.03-0.05-0.05-0.06-0.04-0.03-0.03-0.03-0.02-0.03-0.01-0.01-0.01-0.01-0.01-0.00
Surprise---------------------------------------
Timing-----------------------------Pre-market---------

Key Statistics & Ratios

Market Cap148.48M
Enterprise Value157.67M
Trailing P/E0.00
Forward P/E0.00
Price / Sales106.90
Price / Book204.14
EPS-0.03
Book Value0.001
Revenue (TTM)1.39M
Gross Profit (TTM)1.34M
EBITDA-12.95M
Profit Margin0.00%
Operating Margin-2773.98%
Return on Equity-1223.24%
Return on Assets-11.79%
Shares Outstanding1.35B
Shares Float1.26B
Beta0.88
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%